Trials / Completed
CompletedNCT03834610
Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction
Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction: A Double-blinded Randomized Controlled Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- Male
- Age
- 35 Years – 56 Years
- Healthy volunteers
- Accepted
Summary
Tadalafil is an effective oral therapy in erectile dysfunction. L-arginine is a pro drug that increase the level of nitrous oxide in the smooth muscles so can increase the strength and duration of erection. this clinical trials compare the daily oral L-arginine plus tadalafil in treatment of erectile dysfunction in diabetic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-arginine 5 gm oral caps | oral L-arginine 5 gm daily for 8 weeks |
| DRUG | Tadalafil 10 MG | oral daily tadalafil 10mg for 8 weeks |
| DIAGNOSTIC_TEST | serum testosterone level | measurement of serum testosterone level |
| DIAGNOSTIC_TEST | HbA1C | measurement of HbA1C levels |
| DEVICE | penile doppler | penile doppler to measure the degree of erection and penile vasculature |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2019-02-08
- Last updated
- 2019-02-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03834610. Inclusion in this directory is not an endorsement.